The obvious - this company is in a complete mess -the main Hope now is that large shareholders exert influence on the company / remove directors and immediate change is brought in
The company has to radically cut costs -hugely reduce staff costs and any other costs to keep the company from nosediving through it’s cash reserves - the idea of GIA in Europe must be shut down - - get rid of as many staff as they can They have to conserve cash - to allow for sale of the company
They have to put up a big for sale sign - immediately
They have to sell the company to a big pharma who can sell the drug without the vast GIA costs involved
6 dollars - ten dollars if we are very lucky
Unless change occurs very quickly it will get much much worse
The cash will disappear
There is no other choice bar eventual company liquidation when the cash runs out Alm
Studythosestocks - Again thanks your transcript gave me some hope. UK will approve. Dr Bhatt's gravitas will ensure that. The British love to be shown that they are superior. Britannia rules the waves!